28 Nov 2014 10:35
OMEGA DIAGNOSTICS GROUP PLC
("Omega" or the "Company" or the "Group")
Director's Dealing
Omega (AIM: ODX), the medical diagnostics company focused on allergy, food intolerance and infectious disease, announces that Andrew Shepherd, Chief Executive Officer of the Company, today purchased 30,974 ordinary shares in the Company at 17p per share through his SIPP.
Following this transaction, Mr Shepherd's total beneficial holding has increased to 2,677,206 ordinary shares representing 2.5 per cent of the issued ordinary share capital of the Company.
Contacts:
Omega Diagnostics Group PLC | Tel: 01259 763 030 or www.omegadiagnostics.com |
Andrew Shepherd, Chief Executive | |
Kieron Harbinson, Group Finance Director Jag Grewal, Group Sales and Marketing Director | |
finnCap Ltd | Tel: 020 7220 0500 |
Geoff Nash/Christopher Raggett (Corporate Finance) Mia Gardner (Corporate Broking) | |
Walbrook PR Limited | Tel: 020 7933 8780 or omega@walbrookpr.com |
Paul McManus | Mob: 07980 541 893 |
Lianne Cawthorne | Mob: 07584 391 303 |
ODX.L (ODX)